An in Vivo shRNA-Drug Screen to Identify Novel Targeted Therapy Combinations for KRAS Mutant Cancers

doi 10.21236/ada620992
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2016English

In Vivo RNAi Library Screen to Identify Mediators of Disease Progression and Drug Resistance in CML

2006English

Targeted Therapy for Esophagogastric Cancers: A Review

OncoTargets and Therapy
OncologyPharmacology
2012English

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

A Multi-Targeted Probe-Based Strategy to Identify Signaling Vulnerabilities in Cancers

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

The Mode-Of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients With Bone Metastasis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Potential for Targeted Therapy in Prostate Cancers With ERG Abnormalities

Asian Journal of Andrology
MedicineUrology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy